Reinnervate Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 23

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $4.4M

  • Investors
  • 1

Reinnervate General Information

Description

Developer of cell-culturing products designed to offer technologies that facilitate research into cell growth and function in vitro. The company develops and sells 3D cell-culture products that are designed to enable scientists to establish assays and models that mimic the in-vivo growth of cells.

Contact Information

Website
www.reinnervate.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • NETPark Incubator
  • Thomas Wright Way, Sedgefield
  • Durham TS21 3FD
  • England, United Kingdom
Primary Industry
Other Pharmaceuticals and Biotechnology
Acquirer
ReproCELL
Vertical(s)
Life Sciences
Corporate Office
  • NETPark Incubator
  • Thomas Wright Way, Sedgefield
  • Durham TS21 3FD
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Reinnervate Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 01-Jul-2014 $4.4M Completed Generating Revenue
5. Later Stage VC (Series B) 20-Dec-2011 Completed Generating Revenue
4. Later Stage VC (Series A) 27-May-2010 Completed Generating Revenue
3. Early Stage VC 01-Jan-2009 Completed Generating Revenue
2. Early Stage VC 11-Sep-2008 $1.36M $1.36M Completed Generating Revenue
1. University Spin-Out 25-Jul-2002 Completed Startup
To view Reinnervate’s complete valuation and funding history, request access »

Reinnervate Patents

  • 22

    Total Documents Applications and Grants

  • Total Patents Families

  • 3

    Granted

  • 3

    Pending

  • Expiring in next 12 mo

Reinnervate Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-201204303-D0 Substrate Inactive 12-Mar-2012
GB-0817990-D0 Cell culture vessel Inactive 02-Oct-2008
WO-2010038013-A1 Cell culture vessel Inactive 02-Oct-2008
WO-2009024748-A1 Stem cell derived neurotrophic factors Inactive 17-Aug-2007
CA-2662218-A1 Retinoid compounds and their use Inactive 29-Aug-2006 C12N5/0606
To view Reinnervate’s complete patent history, request access »

Reinnervate Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Reinnervate Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Business Investors Group Angel Group Minority
Northstar Ventures Venture Capital Minority
Parkwalk Advisors Venture Capital Minority
To view Reinnervate’s complete investors history, request access »

Ready to get started?

Request a free trial

Reinnervate FAQs

  • When was Reinnervate founded?

    Reinnervate was founded in 2002.

  • Where is Reinnervate headquartered?

    Reinnervate is headquartered in Durham, United Kingdom.

  • What is the size of Reinnervate?

    Reinnervate has 23 total employees.

  • What industry is Reinnervate in?

    Reinnervate’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Reinnervate a private or public company?

    Reinnervate is a Private company.

  • What is the current valuation of Reinnervate?

    The current valuation of Reinnervate is .

  • What is Reinnervate’s current revenue?

    The current revenue for Reinnervate is .

  • How much funding has Reinnervate raised over time?

    Reinnervate has raised $7.28M.

  • Who are Reinnervate’s investors?

    Business Investors Group, Northstar Ventures, and Parkwalk Advisors have invested in Reinnervate.

  • When was Reinnervate acquired?

    Reinnervate was acquired on 01-Jul-2014.

  • Who acquired Reinnervate?

    Reinnervate was acquired by ReproCELL.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process